Explanatory note

These Regulations provide for the terms on which chairmen and members of the Advisory Bodies (the Commission for Human Medicines to be established under section 2A of the Medicines Act 1968, or a committee established under section 4 of the Act) and their sub-committees (known as Expert Advisory Groups) hold and vacate office.

A full regulatory impact assessment has not been produced for this instrument as it has no impact on the costs of business.